Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

In the second half of his Maui Derm recap, George Martin, MD, founder and program director of the meeting, highlights new ...

A phase 3 trial shows that apremilast, an oral phosphodiesterase 4 inhibitor, improves symptoms, disease severity, and ...

Weight-loss interventions seem to improve psoriasis severity and quality of life, according to a review published online Dec.

A new study published in the Journal of American Medical Association showed that psoriasis patients who used antibiotics had ...

On December 1, 2025, Sun Pharmaceutical Industries Ltd. (“Sun Pharma”) announced the launch of ILUMYA® (tildrakizumab-asmn) in India.  ILUMYA® is ...

Psoriasis is a serious skin disease caused by a weakened immune system. It causes red, scaly patches to form on the skin. It ...

When it comes to foundation types, experts agree that liquid foundations generally tend to be best for mature skin. “They ...

At the supermarket, shop for foods high in antioxidants, fiber, and heart-healthy fats that can help reduce inflammation and ...

You can go to the Best Sentences of 2023 here and of 2024 here. Those collections, like this one, wouldn’t exist without your ...

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

Johnson & Johnson wins EU approval for Tremfya in pediatric plaque psoriasis, making it the first IL-23 inhibitor cleared for any pediatric condition.